Home/TumorGen/David H. Crean, Ph.D.
DH

David H. Crean, Ph.D.

Chief Financial Officer

TumorGen

Therapeutic Areas

TumorGen Pipeline

DrugIndicationPhase
Anti-Metastatic Cell Cluster TherapyPrevention of Cancer MetastasisPre-clinical